Ajooni Biotech Limited (NSE:AJOONI)

Ajooni Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	152.87	68.3	4.28	3.09	0.57	2.44
Short-Term Investments	-	4.4	0.02	3.26	1.18	1.6
Cash & Short-Term Investments	152.87	72.7	4.3	6.35	1.75	4.04
Cash Growth	-10.17%	1589.22%	-32.25%	262.20%	-56.61%	112.78%
Accounts Receivable	158.17	162.16	129.59	205.51	138.4	137.12
Other Receivables	-	5.52	0.79	3.24	0.12	1.1
Receivables	357.57	167.68	130.38	208.75	138.52	138.22
Inventory	232.56	239.87	153.67	69.94	58.82	53.76
Prepaid Expenses	-	1.37	3.14	1.41	0.27	0.15
Other Current Assets	4.7	138.42	31.78	60.26	19.9	18.12
Total Current Assets	747.7	620.04	323.28	346.71	219.27	214.29
Property, Plant & Equipment	224.51	112.26	112.43	65.51	62.05	51.62
Long-Term Investments	33.6	34.94	21.36	37.37	7.04	11.48
Other Intangible Assets	4.19	4.79	-	-	-	-
Long-Term Deferred Tax Assets	3.6	3.79	3.12	2.72	1.82	1.47
Long-Term Deferred Charges	-	-	-	-	-	1.41
Other Long-Term Assets	27.51	174.69	15	135	-	0
Total Assets	1,041	950.51	475.2	587.31	290.18	280.26
Accounts Payable	44.54	29.3	13.38	98.46	66.22	52.84
Accrued Expenses	-	5.81	2.68	3.21	1.84	1.23
Short-Term Debt	-	-	-	28.69	18.2	39.62
Current Portion of Long-Term Debt	-	-	4.86	5.62	9.54	9.24
Current Income Taxes Payable	3.21	10.24	8.75	5.42	4.48	1.5
Other Current Liabilities	4.52	2.86	0.44	10.69	0.32	0.35
Total Current Liabilities	52.27	48.21	30.11	152.09	100.59	104.78
Long-Term Debt	88.71	19.4	16.82	17.47	25.76	18.98
Pension & Post-Retirement Benefits	2.21	2.11	1.2	1.06	-	-
Other Long-Term Liabilities	-	-	0	0.01	-0	-
Total Liabilities	143.18	69.72	48.13	170.62	126.35	123.76
Common Stock	344.49	344.49	175.23	175.23	100.06	100.06
Additional Paid-In Capital	-	431.86	177.97	177.97	30.07	30.07
Retained Earnings	-	120.07	86.9	66.2	55	44.51
Comprehensive Income & Other	553.44	-15.63	-13.02	-2.7	-21.31	-18.13
Shareholders' Equity	897.92	880.79	427.08	416.69	163.82	156.51
Total Liabilities & Equity	1,041	950.51	475.2	587.31	290.18	280.26
Total Debt	88.71	19.4	21.68	51.77	53.51	67.84
Net Cash (Debt)	64.16	53.31	-17.37	-45.42	-51.75	-63.79
Net Cash Per Share	1.28	0.31	-0.20	-0.76	-1.02	-1.28
Filing Date Shares Outstanding	116.51	172.24	87.61	87.61	50.03	50.03
Total Common Shares Outstanding	116.51	172.24	87.61	87.61	50.03	50.03
Working Capital	695.43	571.83	293.18	194.63	118.68	109.51
Book Value Per Share	7.71	5.11	4.87	4.76	3.27	3.13
Tangible Book Value	893.73	876	427.08	416.69	163.82	156.51
Tangible Book Value Per Share	7.67	5.09	4.87	4.76	3.27	3.13
Land	-	59.15	59.15	20.21	11.17	11.17
Buildings	-	28.94	18.32	18.51	18.51	-
Machinery	-	77.68	71.23	60.92	59.02	41.74
Construction In Progress	-	2.93	9.25	2.62	-	15.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.